Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon L Amidon

Showing results (41-50 of 185) with videos related to

Pageof 19
Sort By:
Life Sciences|November 1, 2002
Possible degradative process of cholecystokinin analogs in rabbit jejunum brush-border membrane vesiclesSheng-Fang Su, Gordon L Amidon, Hye J Lee
Journal of Medicinal Chemistry|April 30, 2004
Lessons learned from marketed and investigational prodrugsPeter Ettmayer, Gordon L Amidon, Bernd Clement, et al.
Molecular Pharmaceutics|September 9, 2010
Physiological parameters for oral delivery and in vitro testingDeanna M Mudie, Gordon L Amidon, Gregory E Amidon
Clinical Pharmacokinetics|April 6, 2006
Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidineEkarat Jantratid, Sompol Prakongpan, Gordon L Amidon, et al.
Pharmaceutical Research|March 23, 2007
Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanomaSachin Mittal, Xueqin Song, Balvinder S Vig, et al.
Journal of Pharmaceutical Sciences|March 30, 2016
The Evaluation of In Vitro Drug Dissolution of Commercially Available Oral Dosage Forms for Itraconazole in Gastrointestinal Simulator With Biorelevant MediaKazuki Matsui, Yasuhiro Tsume, Gregory E Amidon, et al.
Molecular Pharmaceutics|May 19, 2015
In Vitro Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting in Vivo Dissolution and Drug-Drug Interaction Caused by Acid-Reducing AgentsKazuki Matsui, Yasuhiro Tsume, Gregory E Amidon, et al.
Journal of Pharmaceutical Sciences|September 25, 2014
Evaluation of a three compartment in vitro gastrointestinal simulator dissolution apparatus to predict in vivo dissolutionSusumu Takeuchi, Yasuhiro Tsume, Gregory E Amidon, et al.
Molecular Pharmaceutics|June 12, 2013
Ion pairing with bile salts modulates intestinal permeability and contributes to food-drug interaction of BCS class III compound trospium chlorideChristian A Heinen, Stefan Reuss, Gordon L Amidon, et al.
Biopharmaceutics & Drug Disposition|July 21, 2012
In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofenYasuhiro Tsume, Peter Langguth, Alfredo Garcia-Arieta, et al.
Pageof 19

Showing results (41-50 of 185) with videos related to

Sort By:
Pageof 19
Life Sciences|November 1, 2002
Possible degradative process of cholecystokinin analogs in rabbit jejunum brush-border membrane vesiclesSheng-Fang Su, Gordon L Amidon, Hye J Lee
Journal of Medicinal Chemistry|April 30, 2004
Lessons learned from marketed and investigational prodrugsPeter Ettmayer, Gordon L Amidon, Bernd Clement, et al.
Molecular Pharmaceutics|September 9, 2010
Physiological parameters for oral delivery and in vitro testingDeanna M Mudie, Gordon L Amidon, Gregory E Amidon
Clinical Pharmacokinetics|April 6, 2006
Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidineEkarat Jantratid, Sompol Prakongpan, Gordon L Amidon, et al.
Pharmaceutical Research|March 23, 2007
Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanomaSachin Mittal, Xueqin Song, Balvinder S Vig, et al.
Journal of Pharmaceutical Sciences|March 30, 2016
The Evaluation of In Vitro Drug Dissolution of Commercially Available Oral Dosage Forms for Itraconazole in Gastrointestinal Simulator With Biorelevant MediaKazuki Matsui, Yasuhiro Tsume, Gregory E Amidon, et al.
Molecular Pharmaceutics|May 19, 2015
In Vitro Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting in Vivo Dissolution and Drug-Drug Interaction Caused by Acid-Reducing AgentsKazuki Matsui, Yasuhiro Tsume, Gregory E Amidon, et al.
Journal of Pharmaceutical Sciences|September 25, 2014
Evaluation of a three compartment in vitro gastrointestinal simulator dissolution apparatus to predict in vivo dissolutionSusumu Takeuchi, Yasuhiro Tsume, Gregory E Amidon, et al.
Molecular Pharmaceutics|June 12, 2013
Ion pairing with bile salts modulates intestinal permeability and contributes to food-drug interaction of BCS class III compound trospium chlorideChristian A Heinen, Stefan Reuss, Gordon L Amidon, et al.
Biopharmaceutics & Drug Disposition|July 21, 2012
In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofenYasuhiro Tsume, Peter Langguth, Alfredo Garcia-Arieta, et al.
Pageof 19